A Canadian focused, healthcare company with global reach and a diversified portfolio of commercial products
Enhancing Patient Quality of Life
Miravo is committed to providing innovative and cost-effective products that enhance patient quality of life.
The Company's products target several therapeutic areas, including pain, allergy, neurology and dermatology.
SNN Network Canada Virtual Event
December 8, 2021 / 11:00 am ET
Miravo Hosted Investor Webcast
December 2, 2021 / 2:00 pm ET
SNN Interview with Jesse Ledger, Miravo's President & CEO discussing the Suvexx Commercialization Launch and Trends in Specialty Pharmaceuticals
November 30, 2021
Smallcap Discoveries Interview
with Jesse Ledger, Miravo's President & CEO
November 25, 2021